Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
Clin Oncol (R Coll Radiol) ; 17(8): 650-4, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16372493

ABSTRACT

This report outlines a case of Gorlin syndrome, the diagnosis of which was delayed for many years, and raises a number of important issues. These are the spectrum of late radiotherapy effects, particularly after treatment for benign disease, and the importance of considering the possibility of the presence of a genetic syndrome predisposing to cancer in all individuals before starting any treatment. As our knowledge of genetic syndromes expands, this will become increasingly important. Finally, if a genetic predisposition to cancer is suspected, consideration should be given to obtaining a blood sample from the affected patient for DNA storage, particularly if their prognosis is limited. Currently, genetic testing can only be instituted in most families by first obtaining DNA from an individual affected by cancer, as most genetic mutations are unique to a family. If all relatives with cancer have died, then, at this time, genetic testing cannot usually be attempted, unless such samples have previously been stored.


Subject(s)
Basal Cell Nevus Syndrome/genetics , Genetic Predisposition to Disease , Aged , Basal Cell Nevus Syndrome/diagnosis , Genetic Testing , Humans , Male
3.
Am J Hum Genet ; 72(5): 1261-7, 2003 May.
Article in English | MEDLINE | ID: mdl-12696020

ABSTRACT

The putative locus for hereditary mixed polyposis syndrome (HMPS) in a large family of Ashkenazi descent (SM96) was previously reported to map to chromosome sub-bands 6q16-q21. However, new clinical data, together with molecular data from additional family members, have shown 6q linkage to be incorrect. A high-density genomewide screen for the HMPS gene was therefore performed on SM96, using stringent criteria for assignment of affection status to minimize phenocopy rates. Significant evidence of linkage was found only on a region on chromosome 15q13-q14. Since this region encompassed CRAC1, a locus involved in inherited susceptibility to colorectal adenomas and carcinomas in another Ashkenazi family (SM1311), we determined whether HMPS and CRAC1 might be the same. We found that affected individuals from both families shared a haplotype between D15S1031 and D15S118; the haplotype was rare in the general Ashkenazi population. A third informative family, SM2952, showed linkage of disease to HMPS/CRAC1 and shared the putative ancestral haplotype, as did a further two families, SMU and RF. Although there are probably multiple causes of the multiple colorectal adenoma and cancer phenotype in Ashkenazim, an important one is the HMPS/CRAC1 locus on 15q13-q14.


Subject(s)
Adenomatous Polyposis Coli/genetics , Chromosomes, Human, Pair 15/genetics , Genetic Linkage , Haplotypes/genetics , Jews/genetics , Chromosome Mapping , Chromosomes, Human, Pair 6/genetics , Female , Genetic Predisposition to Disease , Genetic Testing , Humans , Lod Score , Male , Pedigree
4.
J Med Genet ; 39(7): 478-83, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12114478

ABSTRACT

INTRODUCTION: Lymphoedema-distichiasis syndrome (LD) (OMIM 153400) is a rare, primary lymphoedema of pubertal onset, associated with distichiasis. Causative mutations have now been described in FOXC2, a forkhead transcription factor gene. Numerous clinical associations have been reported with this condition, including congenital heart disease, ptosis, varicose veins, cleft palate, and spinal extradural cysts. SUBJECTS: We report clinical findings in 74 affected subjects from 18 families and six isolated cases. All of them were shown to have mutations in FOXC2 with the exception of one family who had two affected subjects with lymphoedema and distichiasis and linkage consistent with the 16q24 locus. RESULTS: The presence of lymphoedema was highly penetrant. Males had an earlier onset of lymphoedema and a significantly increased risk of complications. Lymphatic imaging confirmed the earlier suggestion that LD is associated with a normal or increased number of lymphatic vessels rather than the hypoplasia or aplasia seen in other forms of primary lymphoedema. Distichiasis was 94.2% penetrant, but not always symptomatic. Associated findings included ptosis (31%), congenital heart disease (6.8%), and cleft palate (4%). Other than distichiasis, the most commonly occurring anomaly was varicose veins of early onset (49%). This has not been previously reported and suggests a possible developmental role for FOXC2 in both venous and lymphatic systems. This is the first gene that has been implicated in the aetiology of varicose veins. CONCLUSION: Unlike previous publications, the thorough clinical characterisation of our patients permits more accurate prediction of various phenotypic abnormalities likely to manifest in subjects with FOXC2 mutations.


Subject(s)
Abnormalities, Multiple/genetics , Chromosomes, Human, Pair 16/genetics , DNA-Binding Proteins/genetics , Eyelashes/abnormalities , Genetic Linkage/genetics , Lymphedema/genetics , Transcription Factors/genetics , Abnormalities, Multiple/diagnostic imaging , Adolescent , Adult , Child , Child, Preschool , Eyelashes/diagnostic imaging , Female , Forkhead Transcription Factors , Humans , Infant , Lymphedema/diagnostic imaging , Lymphography/methods , Male , Phenotype , Puberty/genetics , Radionuclide Imaging , Syndrome
5.
Ann Surg Oncol ; 9(5): 439-43, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12052753

ABSTRACT

BACKGROUND: This study was performed to evaluate the use of total colonoscopy as the optimal screening test in asymptomatic individuals with a family history of colorectal cancer (CRC). METHODS: Colonoscopy was performed in 249 asymptomatic individuals who had one or two first-degree relatives (FDRs) with CRC; individuals with three or more FDRs with CRC were excluded. RESULTS: Eighty-six colonic lesions were found in 51 individuals (51 of 249; 20.5%). Among these 51 subjects, 27 had neoplastic polyps (n = 38) and 29 had metaplastic polyps (n = 44). Although no invasive cancer was detected, in 14 individuals the lesions had a high malignancy potential because of their size and histopathology. We did not confirm a statistically significant difference in the incidence of neoplastic polyps according to the number of affected FDRs. Finally, the presence of metaplastic polyps was a very strong indication for the concomitant presence of metaplastic polyps (P <.0001). CONCLUSIONS: Total colonoscopy is the optimal screening procedure for the examination of asymptomatic individuals with a family history of CRC.


Subject(s)
Colonic Polyps/diagnosis , Colonoscopy , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/genetics , Genetic Predisposition to Disease , Mass Screening , Adult , Aged , Colonic Polyps/complications , Colorectal Neoplasms/pathology , Female , Humans , Incidence , Male , Middle Aged , Pedigree , Predictive Value of Tests
6.
Hum Genet ; 108(6): 546-51, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11499682

ABSTRACT

Lymphoedema-distichiasis (LD) is a dominantly inherited form of primary lymphoedema with onset of lower limb swelling at puberty or later. There is variable penetrance of this disorder, but the most consistently inherited feature is distichiasis, viz. fine hairs arising inappropriately from the meibomian glands. We established linkage of this disorder to 16q24.3 and the gene has recently been identified as the forkhead transcription factor FOXC2. We report the mutational analysis of 14 families with LD. All but one of these pedigrees have small insertions or deletions in the gene, which seem likely to produce haploinsufficiency. The mutation sites are scattered throughout the gene. There is one family with a mis-sense mutation in the forkhead domain of the protein. This base alteration is not a common polymorphism, is co-inherited with the disease and produces a non-conservative amino acid change.


Subject(s)
DNA-Binding Proteins/genetics , Eyelid Diseases/genetics , Lymphedema/genetics , Transcription Factors/genetics , DNA/chemistry , DNA/genetics , DNA Mutational Analysis , Eyelid Diseases/pathology , Family Health , Female , Forkhead Transcription Factors , Humans , Lymphedema/pathology , Male , Mutagenesis, Insertional , Mutation , Pedigree , Sequence Deletion
7.
Am J Med Genet ; 99(2): 172-7, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11241484

ABSTRACT

Familial Incontinentia pigmenti (IP) is a rare X-linked dominant condition. The affected cases have characteristic skin lesions, hair, eye, teeth and nail abnormalities and may also have neurological problems. The diagnosis has traditionally been made on clinical grounds. Segregation analysis has suggested that it is lethal in males. Only one liveborn male has been reported who died at one day of age. Female cases of IP survive because of the moderating effects of Lyonization. This child was the affected son of a female with IP. He had a novel phenotype consistent with hypohidrotic ectodermal dysplasia with immune deficiency (HED-ID) but with additional features: he had major problems with hematological disturbances, failure to thrive due to malabsorption, recurrent infections, generalized osteosclerosis and lymphedema of his lower limbs. He also demonstrated some typical features of IP with a generalized reticular skin hyperpigmentation, sparse hair and delayed eruption of teeth. The gene for NEMO (NF-kappa B Essential Modulator) has recently been shown to be mutated in cases of IP. Furthermore, most (80%) of patients possess a recurrent genomic rearrangement that deletes part of the gene resulting in an inactive NEMO protein. In the male case described here, a NEMO stop codon mutation has been identified that has arisen de novo in his affected mother. This mutation is likely to have a less severe effect on NEMO activity and may explain why this child survived for two years and 7 months.


Subject(s)
Ectodermal Dysplasia/complications , Incontinentia Pigmenti/complications , Codon, Terminator , Ectodermal Dysplasia/genetics , Ectodermal Dysplasia/physiopathology , Female , Hematologic Diseases/complications , Humans , Hypohidrosis/complications , Hypohidrosis/genetics , Hypohidrosis/physiopathology , I-kappa B Kinase , Incontinentia Pigmenti/genetics , Incontinentia Pigmenti/physiopathology , Infant, Newborn , Infections/etiology , Intestinal Absorption , Lymphedema/complications , Male , Mutation , Protein Serine-Threonine Kinases/genetics , Recurrence , Survivors , X Chromosome
8.
Genet Test ; 5(4): 335-8, 2001.
Article in English | MEDLINE | ID: mdl-11960581

ABSTRACT

Blepharophimosis/ptosis/epicanthus inversus syndrome (BPES) is an autosomal dominant disorder that is characterized by distinctive eyelid abnormalities. Two clinical subtypes have been described in which type I, but not type II, is associated with premature ovarian failure. Both types of BPES are linked to 3q22-23, and the gene has recently been identified as the putative forkhead transcription factor FOXL2. We report mutation screening of FOXL2 in two families with this condition. The two mutations detected were frameshift mutations resulting from a small insertion or duplication within the gene. Both mutations would result in the production of novel carboxyl terminii, one terminating the predicted protein earlier than the wild type, and the other giving rise to a larger protein product, assuming these proteins or their mRNA were not degraded. Based on the present data, this would suggest that the first family should be type I and the second, type II. Although there is evidence of infertility in the first family, all 3 females in the youngest generation have normal pelvic ultrasound and hormone levels, suggesting that the divide between types I and II may not be as distinct as has been suggested.


Subject(s)
Blepharophimosis/genetics , Blepharoptosis/genetics , DNA-Binding Proteins/genetics , Frameshift Mutation/genetics , Transcription Factors/genetics , Female , Forkhead Box Protein L2 , Forkhead Transcription Factors , Humans , Male , Pedigree , Syndrome
9.
Fam Cancer ; 1(3-4): 189-95, 2001.
Article in English | MEDLINE | ID: mdl-14574178

ABSTRACT

It is not uncommon for cancer geneticists to be referred families with apparently Mendelian co-inheritance of breast and bowel cancer. Such families present a particular problem as regards the intensity of their screening for these diseases and the utility of genetic testing. Many 'breast-colon' cancer families probably result from chance clustering of two common cancers. Other 'breast-colon' cancer families may result from known cancer syndromes, such as hereditary breast-ovarian cancer or hereditary non-polyposis colon cancer, either by conferring a high risk of one cancer type and a slightly increased risk of the other, or through a predisposition to one of the two cancers and chance occurrence of the other. Anecdotally, however, many geneticists wonder about the existence of a distinct 'breast-colon cancer syndrome', since some families present good a priori evidence of genetic disease and yet cannot readily be accounted for by known genes or chance. The identification of unknown 'breast-colon cancer' genes is likely to be difficult, relying primarily on candidate gene analysis, including loci separately implicated in breast or colorectal cancer, or in other multiple cancer syndromes. Studies such as those on APC I1307K and CHEK2 1100delC may suggest the way forward for the identification of 'breast-colon cancer' genes.


Subject(s)
Breast Neoplasms/genetics , Colorectal Neoplasms/genetics , Genetic Heterogeneity , Genetic Predisposition to Disease , Adult , Checkpoint Kinase 2 , Female , Gene Frequency , Genes, APC , Humans , Male , Mutation , Pedigree , Phenotype , Protein Serine-Threonine Kinases/genetics
11.
Nat Genet ; 25(4): 419-22, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10932186

ABSTRACT

The autosomal recessive form of Robinow syndrome (RRS; MIM 268310) is a severe skeletal dysplasia with generalized limb bone shortening, segmental defects of the spine, brachydactyly and a dysmorphic facial appearance. We previously mapped the gene mutated in RRS to chromosome 9q22 (ref. 4), a region that overlaps the locus for autosomal dominant brachydactyly type B (refs 5,6). The recent identification of ROR2, encoding an orphan receptor tyrosine kinase, as the gene mutated in brachydactyly type B (BDB1; ref. 7) and the mesomelic dwarfing in mice homozygous for a lacZ and/or a neo insertion into Ror2 (refs 8,9) made this gene a candidate for RRS. Here we report homozygous missense mutations in both intracellular and extracellular domains of ROR2 in affected individuals from 3 unrelated consanguineous families, and a nonsense mutation that removes the tyrosine kinase domain and all subsequent 3' regions of the gene in 14 patients from 7 families from Oman. The nature of these mutations suggests that RRS is caused by loss of ROR2 activity. The identification of mutations in three distinct domains (containing Frizzled-like, kringle and tyrosine kinase motifs) indicates that these are all essential for ROR2 function.


Subject(s)
Abnormalities, Multiple/genetics , Limb Deformities, Congenital/genetics , Receptors, Cell Surface/genetics , Abnormalities, Multiple/pathology , Alleles , DNA/chemistry , DNA/genetics , DNA Mutational Analysis , Face/abnormalities , Genes, Dominant , Genes, Recessive , Humans , Limb Deformities, Congenital/pathology , Molecular Sequence Data , Mutation , Polymorphism, Restriction Fragment Length , Polymorphism, Single-Stranded Conformational , Receptor Protein-Tyrosine Kinases/genetics , Receptor Tyrosine Kinase-like Orphan Receptors , Syndactyly , Syndrome
12.
Anticancer Res ; 20(3B): 1991-4, 2000.
Article in English | MEDLINE | ID: mdl-10928139

ABSTRACT

BACKGROUND: Most patients with colorectal cancer (CRC) develop clinical signs and symptoms which are not specific for CRC, and usually at a late stage of the disease, resulting in a considerable delay of the diagnosis. In our study we examined patients with bowel symptoms which were at increased risk for developing CRC, because of their family history. METHODS: Over the last 6 years, colonoscopy was performed in 203 patients with colorectal symptoms, who had at least one Ist degree relative with CRC, at the Colorectal Surgery Unit of St George's Hospital. Five hundred ninety two individuals without CRC family history and with either rectal bleeding (n = 479), or with change of bowel habits (n = 113) were used as control group. RESULTS: In the group of patients with family history of CRC 81 colonic lesions were found in 53 patients (53/203, 26%). Patients with family history of CRC were grouped in three categories according to their main symptom. In the subgroup of patients with bleeding (n = 129) there were found 46 colonic lesions in 33 patients. In the subgroup of patients with change of bowel habits (n = 45) we were able to detect 39 colonic lesions. In the group of patients with abdominal pain (n = 29) 4 patients had a metaplastic polyp and one patient had a neoplastic polyp. With regard to the number of 1st degree relatives with CRC, we found that 16/172 (9%) patients with one such relative and 4/31 (13%) of the patients with two relatives were diagnosed with neoplastic polyps. CONCLUSIONS: Total colonoscopy (TC) is an excellent diagnostic procedure for the examination of symptomatic patients with positive family history of colorectal cancer. TC has a diagnostic role detecting the cause of symptoms or excluding the presence of malignancy. Simultaneous resection of the neoplastic and metaplastic polyps, provides an additional, secondary prevention of CRC.


Subject(s)
Abdominal Pain/etiology , Adenocarcinoma/diagnosis , Colonic Polyps/diagnosis , Colonoscopy , Colorectal Neoplasms/diagnosis , Constipation/etiology , Diarrhea/etiology , Gastrointestinal Hemorrhage/etiology , Adenocarcinoma/complications , Adenocarcinoma/epidemiology , Adenocarcinoma/genetics , Adult , Aged , Aged, 80 and over , Colonic Diseases/complications , Colonic Diseases/diagnosis , Colonic Diseases/epidemiology , Colonic Polyps/complications , Colonic Polyps/epidemiology , Colonic Polyps/genetics , Colorectal Neoplasms/complications , Colorectal Neoplasms/epidemiology , Colorectal Neoplasms/genetics , Female , Genetic Predisposition to Disease , Humans , Male , Middle Aged , Prevalence
13.
Hum Genet ; 106(3): 351-4, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10798366

ABSTRACT

Autosomal recessive Robinow syndrome is a form of mesomelic dwarfism with multiple rib and vertebral anomalies. Using autozygosity mapping we have identified a genetic locus (RBNW1) for this syndrome at chromosome 9q22 in seven consanguineous families from Oman. Our results indicate that the gene lies within a 4 cM region between markers D9S1836 and D9S1803 (maximum multipoint LOD score 12.3). In addition, we have analysed two non-Omani families with autosomal recessive Robinow and found no genetic heterogeneity.


Subject(s)
Chromosomes, Human, Pair 9/genetics , Dwarfism/genetics , Bone and Bones/abnormalities , Brazil , Chromosome Mapping , Consanguinity , Genes, Recessive , Genetic Linkage , Haplotypes , Humans , Lod Score , Microsatellite Repeats , Oman , United Kingdom
15.
Am J Hum Genet ; 65(2): 427-32, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10417285

ABSTRACT

Lymphedema-distichiasis (LD) is a dominantly inherited syndrome with onset of lymphedema at or just after puberty. Most affected individuals have distichiasis-fine hairs arising inappropriately from the eyelid meibomian glands-which is evident from birth. A study of three families with LD has shown linkage to chromosome 16q24.3, and subsequent analysis of the region for recombinant genes places the locus between D16S422 and D16S3074, a distance of approximately 16 cM. Possible candidate genes in this interval include the N-proteinase for type 3 collagen, PCOLN3; the metalloprotease PRSM1; and the cell matrix-adhesion regulator, CMAR.


Subject(s)
Chromosomes, Human, Pair 16/genetics , Lymphedema/genetics , Physical Chromosome Mapping , Female , Genetic Linkage/genetics , Genetic Markers/genetics , Humans , Lymphedema/diagnosis , Male , Molecular Sequence Data , Pedigree
16.
Hum Mol Genet ; 8(8): 1461-72, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10400993

ABSTRACT

Germline mutations in the tumour suppressor gene PTEN have been implicated in two hamartoma syndromes that exhibit some clinical overlap, Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndrome (BRR). PTEN maps to 10q23 and encodes a dual specificity phosphatase, a substrate of which is phosphatidylinositol 3,4,5-triphosphate, a phospholipid in the phosphatidylinositol 3-kinase pathway. CS is characterized by multiple hamartomas and an increased risk of benign and malignant disease of the breast, thyroid and central nervous system, whilst the presence of cancer has not been formally documented in BRR. The partial clinical overlap in these two syndromes is exemplified by the hallmark features of BRR: macrocephaly and multiple lipomas, the latter of which occur in a minority of individuals with CS. Additional features observed in BRR, which may also occur in a minority of CS patients, include Hashimoto's thyroiditis, vascular malformations and mental retardation. Pigmented macules of the glans penis, delayed motor development and neonatal or infant onset are noted only in BRR. In this study, constitutive DNA samples from 43 BRR individuals comprising 16 sporadic and 27 familial cases, 11 of which were families with both CS and BRR, were screened for PTEN mutations. Mutations were identified in 26 of 43 (60%) BRR cases. Genotype-phenotype analyses within the BRR group suggested a number of correlations, including the association of PTEN mutation and cancer or breast fibroadenoma in any given CS, BRR or BRR/CS overlap family ( P = 0.014), and, in particular, truncating mutations were associated with the presence of cancer and breast fibroadenoma in a given family ( P = 0.024). Additionally, the presence of lipomas was correlated with the presence of PTEN mutation in BRR patients ( P = 0.028). In contrast to a prior report, no significant difference in mutation status was found in familial versus sporadic cases of BRR ( P = 0.113). Comparisons between BRR and a previously studied group of 37 CS families suggested an increased likelihood of identifying a germline PTEN mutation in families with either CS alone or both CS and BRR when compared with BRR alone ( P = 0.002). Among CS, BRR and BRR/CS overlap families that are PTEN mutation positive, the mutation spectra appear similar. Thus, PTEN mutation-positive CS and BRR may be different presentations of a single syndrome and, hence, both should receive equal attention with respect to cancer surveillance.


Subject(s)
Abnormalities, Multiple/genetics , Hamartoma Syndrome, Multiple/genetics , Phosphoric Monoester Hydrolases/genetics , Tumor Suppressor Proteins , Abnormalities, Multiple/pathology , Cells, Cultured , Chromosome Deletion , Chromosome Mapping , Chromosomes, Human, Pair 10/genetics , Cohort Studies , Craniofacial Abnormalities/genetics , Family Health , Female , Genetic Carrier Screening , Genetic Markers , Genotype , Germ-Line Mutation , Hamartoma Syndrome, Multiple/pathology , Heterozygote , Humans , Intellectual Disability/genetics , Male , Mutation , PTEN Phosphohydrolase , Pedigree , Phenotype , Syndrome
17.
Br J Dermatol ; 140(5): 849-52, 1999 May.
Article in English | MEDLINE | ID: mdl-10354021

ABSTRACT

Somatic mutations within c-kit have been reported in individuals with mastocytoses, including urticaria pigmentosa (UP). We have identified three siblings with UP. We aimed to determine whether the c-kit proto-oncogene was playing a part in the aetiology of UP in these three siblings. Using seven microsatellite repeat markers spanning an 8-cM interval encompassing the c-kit gene we followed the transmission of the c-kit gene in this family. Furthermore, single-strand conformation polymorphism analysis was used to scan exon 17 of the c-kit gene for mutations in genomic DNA of all family members and somatic DNA extracted from skin of the eldest affected sibling, the proband. No mutations were found in exon 17 in either genomic DNA of all family members or somatic DNA of the proband. Patients with UP have been shown to possess somatic mutations of the c-kit gene. However, this locus has been excluded as playing a part in the three siblings examined here in whom a second gene locus must be determining their UP. Therefore, this study emphasizes genetic heterogeneity in UP. Future study to identify primary molecular determinants of UP should include affected sib-pair studies.


Subject(s)
Proto-Oncogene Proteins c-kit/genetics , Urticaria Pigmentosa/genetics , Child, Preschool , Chromosome Mapping , DNA Mutational Analysis , Exons , Female , Haplotypes , Heterozygote , Humans , Male , Pedigree , Polymorphism, Single-Stranded Conformational , Proto-Oncogene Mas
19.
J Med Genet ; 35(11): 881-5, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9832031

ABSTRACT

Cowden syndrome (CS) or multiple hamartoma syndrome (MIM 158350) is an autosomal dominant disorder with an increased risk for breast and thyroid carcinoma. The diagnosis of CS, as operationally defined by the International Cowden Consortium, is made when a patient, or family, has a combination of pathognomonic major and/or minor criteria. The CS gene has recently been identified as PTEN, which maps at 10q23.3 and encodes a dual specificity phosphatase. PTEN appears to function as a tumour suppressor in CS, with between 13-80% of CS families harbouring germline nonsense, missense, and frameshift mutations predicted to disrupt normal PTEN function. To date, only a small number of tumour suppressor genes, including BRCA1, BRCA2, and p53, have been associated with familial breast or breast/ovarian cancer families. Given the involvement of PTEN in CS, we postulated that PTEN was a likely candidate to play a role in families with a "CS-like" phenotype, but not classical CS. To answer these questions, we gathered a series of patients from families who had features reminiscent of CS but did not meet the Consortium Criteria. Using a combination of denaturing gradient gel electrophoresis (DGGE), temporal temperature gel electrophoresis (TTGE), and sequence analysis, we screened 64 unrelated CS-like subjects for germline mutations in PTEN. A single male with follicular thyroid carcinoma from one of these 64 (2%) CS-like families harboured a germline point mutation, c.209T-->C. This mutation occurred at the last nucleotide of exon 3 and within a region homologous to the cytoskeletal proteins tensin and auxilin. We conclude that germline PTEN mutations play a relatively minor role in CS-like families. In addition, our data would suggest that, for the most part, the strict International Cowden Consortium operational diagnostic criteria for CS are quite robust and should remain in place.


Subject(s)
Germ-Line Mutation , Hamartoma Syndrome, Multiple/genetics , Phosphoric Monoester Hydrolases/genetics , Tumor Suppressor Proteins , Female , Humans , Male , PTEN Phosphohydrolase , Pedigree , Polymorphism, Genetic
20.
Circulation ; 97(20): 2049-58, 1998 May 26.
Article in English | MEDLINE | ID: mdl-9610536

ABSTRACT

BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disease of unknown etiology that causes arrhythmias, heart failure, and sudden death. Diagnosis can be difficult, and this hampers investigation of its molecular basis. Forms of ARVC in which gene penetrance and disease expression are greater should facilitate genetic study. We undertook a clinical and genetic investigation of Naxos disease, originally described by Protonotarios in 1986. This disease constitutes the triad of ARVC, diffuse nonepidermolytic palmoplantar keratoderma, and woolly hair. METHODS AND RESULTS: We evaluated the population of Naxos, Greece, to identify probands, which was followed by family screening. Twenty-one affected persons from 9 families of 150 persons were identified. Linkage analysis was performed with microsatellite markers. The disease locus mapped to 17q21. A peak 2-point LOD score of 3.62 at theta=0.0 was found with a marker within intron 4 of the keratin 9 gene, a member of the type I (acidic) keratin family. A preserved homozygous disease haplotype was identified. Haplotype analysis delimited the disease interval. CONCLUSIONS: Hair and skin abnormalities were found to be reliable markers of subsequent heart disease. This suggests the presence of a single mutant gene with novel cardiac, skin, and hair function or two or more tightly linked disease genes. Recessive inheritance of Naxos disease and a founder effect were demonstrated. Identification of a fully informative genetic marker linked to the disease and uncommon in the background population may be of use as a test to identify disease gene carriers.


Subject(s)
Arrhythmogenic Right Ventricular Dysplasia/genetics , Chromosome Mapping , Chromosomes, Human, Pair 17 , Hair Diseases/genetics , Keratoderma, Palmoplantar/genetics , Female , Genetic Linkage , Humans , Male , Pedigree
SELECTION OF CITATIONS
SEARCH DETAIL
...